新西兰生物产业的规模并不十分引人注目，但却是新西兰经济中不可忽视的组成部分，其生物科技方面的优势领域主要是农业生物技术和生物医学两方面，例如大型动植物、生物安全、环境保护、神经科学、心血管疾病、结核与哮喘、糖尿病和癌症等研究领域。新西兰政府十分重视生物科技和产业的发展，在其2002年颁布的《创新增长框架》计划中，将生物技术列为未来的三大经济增长支柱之一，将加大对生物科技和产业的投入作为新西兰向高技术经济转型的重要举措。
AbstractThe bioindustry of New Zealand does not rank high world widely in the sense of the scale. However it is the indispensable part of the country's economy. Prestigious fields of New Zealand biotechnology focus on agribiotechnology and biomedicine research, e.g. large animal and plantbased research, the researches on biosafety, environment protection, neuroscience, cardiovascular diseases, tuberculosis and asthma, diabetes, tumor, and etc. The New Zealand government has attached great importance to the development of biotechnology and bioindustry. The officially announced “The Growth and Innovation Framework” in 2002 listed biotechnology as one of the 3 pillars underpinning the future economy of New Zealand and planned to increase the investment in biotechnology and bioindustry as the important measure for the New Zealand's transformation to hightech economy. Key words
范明杰，付红波，赵清华，李玉洁，李晓娟，安道昌. 新西兰生物科技及产业现状及特点[J]. 中国生物工程杂志, 2008, 28(10): 5-7.
https://manu60.magtech.com.cn/biotech/CN/Y2008/V28/I10/5
Cited
